Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;11(3):275-80.
doi: 10.1097/00006982-199111030-00001.

Variations in clinical features of the Vogt-Koyanagi-Harada syndrome

Affiliations

Variations in clinical features of the Vogt-Koyanagi-Harada syndrome

J Beniz et al. Retina. 1991.

Abstract

Forty-eight cases of the Vogt-Koyanagi-Harada (VKH) syndrome occurring in patients residing in southern California were reviewed. Thirty-six patients were Hispanic and 12 of other racial groups. Symptoms of meningismus, predominantly headache, were present in 32 (67%) cases, but the other characteristic neurologic symptoms, i.e., tinnitus and dysacusis, were present in only eight (17%) and six (13%) cases, respectively. Dermatologic changes were rare; vitiligo occurred in five (10%) patients, alopecia in six (13%), and poliosis in three (6%). In this patient population, extraocular signs and symptoms of the VKH syndrome, other than headache, were unusual. The ocular manifestations of the VKH syndrome are more constant and include iridocyclitis, vitritis, diffuse swelling of the choroid, serous retinal detachment, and optic disc hyperemia. Procedures that may aid in the diagnosis include lumbar puncture, fluorescein angiography, and standardized echography. The ophthalmologist must be prepared to make this diagnosis and initiate treatment with high-dose systemic steroids based on the typical ocular findings even in the absence of other (extraocular) manifestations of this disease.

PubMed Disclaimer

Similar articles

  • Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
    Vukojević M, Vukojevic N, Vuković A, Rupčić B, Blažević M, Blažević A. Vukojević M, et al. Acta Dermatovenerol Croat. 2023 Dec;31(4):229-231. Acta Dermatovenerol Croat. 2023. PMID: 38651852
  • Echographic features of the Vogt-Koyanagi-Harada syndrome.
    Forster DJ, Cano MR, Green RL, Rao NA. Forster DJ, et al. Arch Ophthalmol. 1990 Oct;108(10):1421-6. doi: 10.1001/archopht.1990.01070120069031. Arch Ophthalmol. 1990. PMID: 2222275
  • [Vogt-Koyanagi-Harada disease].
    Kjeka O, Krohn J. Kjeka O, et al. Tidsskr Nor Laegeforen. 2005 Aug 25;125(16):2195-7. Tidsskr Nor Laegeforen. 2005. PMID: 16138134 Norwegian.
  • Vogt-Koyanagi-Harada syndrome.
    Moorthy RS, Inomata H, Rao NA. Moorthy RS, et al. Surv Ophthalmol. 1995 Jan-Feb;39(4):265-92. doi: 10.1016/s0039-6257(05)80105-5. Surv Ophthalmol. 1995. PMID: 7725227 Review.
  • Vogt-Koyanagi-Harada disease.
    O'Keefe GA, Rao NA. O'Keefe GA, et al. Surv Ophthalmol. 2017 Jan-Feb;62(1):1-25. doi: 10.1016/j.survophthal.2016.05.002. Epub 2016 May 27. Surv Ophthalmol. 2017. PMID: 27241814 Review.

Cited by

Publication types

Substances

LinkOut - more resources